Levine James E.
Cardiff Oncology, Inc. · Chief Financial Officer
Levine James E. is listed in filings as Chief Financial Officer at Cardiff Oncology, Inc.. This profile follows SEC Form 4 activity through Mar 13, 2025, including purchase activity. Recent filings connect the profile to Cardiff Oncology, Inc. (CRDF). The current snapshot covers public activity from Dec 18, 2024 to Mar 13, 2025. Reported amounts are shown as $9.8K to $12.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $9.8k2.6k shares | BuyDec 16, 2024 | $3.83 | $1.31 | |
| $15k2.8k shares | BuyDec 17, 2024 | $5.42 | $1.31 |